CA2117073A1 - Mutated growth factor receptor as a drug and its use for the treatment of cancer - Google Patents
Mutated growth factor receptor as a drug and its use for the treatment of cancerInfo
- Publication number
- CA2117073A1 CA2117073A1 CA 2117073 CA2117073A CA2117073A1 CA 2117073 A1 CA2117073 A1 CA 2117073A1 CA 2117073 CA2117073 CA 2117073 CA 2117073 A CA2117073 A CA 2117073A CA 2117073 A1 CA2117073 A1 CA 2117073A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor
- pharmaceutical composition
- composition according
- egf
- wild
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP4129533.1 | 1991-09-05 | ||
| DE19914129533 DE4129533A1 (de) | 1991-09-05 | 1991-09-05 | Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2117073A1 true CA2117073A1 (en) | 1993-03-18 |
Family
ID=6439926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA 2117073 Abandoned CA2117073A1 (en) | 1991-09-05 | 1992-09-07 | Mutated growth factor receptor as a drug and its use for the treatment of cancer |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0667899A1 (de) |
| JP (1) | JPH07502884A (de) |
| CN (1) | CN1071586A (de) |
| AU (1) | AU669857B2 (de) |
| CA (1) | CA2117073A1 (de) |
| DE (1) | DE4129533A1 (de) |
| FI (1) | FI941053A (de) |
| MX (1) | MX9205084A (de) |
| NO (1) | NO940778L (de) |
| NZ (1) | NZ244239A (de) |
| PT (1) | PT100844A (de) |
| WO (1) | WO1993005148A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465623B2 (en) | 1995-05-02 | 2002-10-15 | Garvan Institute Of Medical Research | GDU, a novel signalling protein |
| AUPN274295A0 (en) * | 1995-05-02 | 1995-05-25 | Garvan Institute Of Medical Research | GDU, a novel signalling protein |
| US6790614B1 (en) | 1999-11-19 | 2004-09-14 | Novartis Ag | Selectable cell surface marker genes |
| BRPI0508286B8 (pt) | 2004-03-31 | 2021-05-25 | Dana Farber Cancer Inst Inc | método para determinar a probabilidade de eficácia de um inibidor da tirosina quinase egfr para tratar câncer, uso de um inibidor da tirosina quinase de egfr, sonda, kit, e, par de iniciadores |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68926888T2 (de) * | 1988-01-22 | 1997-01-09 | Zymogenetics Inc | Verfahren zur Herstellung von sekretierten Rezeptoranalogen |
| WO1990008160A1 (en) * | 1989-01-20 | 1990-07-26 | Imperial Cancer Research Technology Ltd. | Growth factor receptor-like peptides without tyrosine-kinase activity |
| GB9001466D0 (en) * | 1990-01-23 | 1990-03-21 | Erba Carlo Spa | Extracellular form of the human fibroblast growth factor receptor |
| DE69031120T2 (de) * | 1989-05-19 | 1998-01-15 | Genentech Inc | Her2 extrazellulare domäne |
| WO1991003489A1 (en) * | 1989-09-08 | 1991-03-21 | The Johns Hopkins University | Structural alterations of the egf receptor gene in human gliomas |
-
1991
- 1991-09-05 DE DE19914129533 patent/DE4129533A1/de not_active Ceased
-
1992
- 1992-09-04 MX MX9205084A patent/MX9205084A/es unknown
- 1992-09-04 PT PT10084492A patent/PT100844A/pt not_active Application Discontinuation
- 1992-09-05 CN CN 92111396 patent/CN1071586A/zh active Pending
- 1992-09-07 NZ NZ24423992A patent/NZ244239A/en unknown
- 1992-09-07 AU AU25185/92A patent/AU669857B2/en not_active Ceased
- 1992-09-07 WO PCT/EP1992/002058 patent/WO1993005148A1/de not_active Application Discontinuation
- 1992-09-07 JP JP5504969A patent/JPH07502884A/ja active Pending
- 1992-09-07 CA CA 2117073 patent/CA2117073A1/en not_active Abandoned
- 1992-09-07 EP EP92918949A patent/EP0667899A1/de not_active Withdrawn
-
1994
- 1994-03-04 NO NO940778A patent/NO940778L/no unknown
- 1994-03-04 FI FI941053A patent/FI941053A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1993005148A1 (de) | 1993-03-18 |
| AU2518592A (en) | 1993-04-05 |
| FI941053A (fi) | 1994-04-08 |
| EP0667899A1 (de) | 1995-08-23 |
| MX9205084A (es) | 1993-05-01 |
| CN1071586A (zh) | 1993-05-05 |
| DE4129533A1 (de) | 1993-03-11 |
| AU669857B2 (en) | 1996-06-27 |
| NO940778D0 (no) | 1994-03-04 |
| FI941053A0 (fi) | 1994-03-04 |
| JPH07502884A (ja) | 1995-03-30 |
| PT100844A (pt) | 1994-05-31 |
| NO940778L (no) | 1994-05-04 |
| NZ244239A (en) | 1995-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5705157A (en) | Methods of treating cancerous cells with anti-receptor antibodies | |
| KR100373813B1 (ko) | 이관능성단백질,그의제조및용도 | |
| JP4620808B2 (ja) | 突然変異上皮成長因子受容体を標的とする試薬および方法 | |
| DE69932600T2 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
| DE69630313T3 (de) | Mit monoklonalem antikörper anti-her2 induzierte apoptosis | |
| EP1469878B1 (de) | Fgfr agoniste | |
| HU215581B (hu) | Eljárás fibroblaszt növekedési faktor receptorok előállítására és terápiás alkalmazására | |
| EA004793B1 (ru) | Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения | |
| JPH05508550A (ja) | 繊維芽細胞生育因子受容体 | |
| WO1997018241A1 (en) | Inducing resistance to tumor growth with soluble igf-1 receptor | |
| KR20170142995A (ko) | 키메라 항원 수용체 및 키메라 항원 수용체가 발현된 t 세포 | |
| USRE39789E1 (en) | Tumor therapy | |
| KR20160016725A (ko) | 암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포 | |
| Lorenzi et al. | FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement. | |
| Masuko et al. | A murine monoclonal antibody that recognizes an extracellular domain of the human c‐erbB‐2 protooncogene product | |
| CA2130089A1 (en) | Protein compound, coding nucleotide sequences, producing cell line and uses thereof | |
| US20060025362A1 (en) | Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation | |
| US8703917B2 (en) | Epidermal growth factor receptor variants and pharmaceutical compositions thereof | |
| CA2117073A1 (en) | Mutated growth factor receptor as a drug and its use for the treatment of cancer | |
| CN115038719A (zh) | 与cd300c抗原或其受体特异性结合的嵌合抗原受体 | |
| US8796421B2 (en) | Human epidermal growth factor receptor variant lacking an exon | |
| BR112021006254A2 (pt) | composições e métodos relativos a células t¿d engenheiradas e não engenheiradas para tratamento de tumores sólidos | |
| CA2217491A1 (en) | Polynucleotide immunogenic agents | |
| JP2001527418A (ja) | グリア細胞系由来の神経栄養因子レセプター | |
| PL195990B1 (pl) | Białko, cząsteczka kwasu nukleinowego i ich zastosowanie oraz zrekombinowany wektor ekspresyjny |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |